Innovation America Innovation America Accelerating the growth of the GLOBAL entrepreneurial innovation economy
Founded by Rich Bendis

ImmuneWorks received funding from BioCrossroads’ first seed fund. Dr. David Wilkes (left) is a founder and chief scientific officer, and Wade Lange is president and CEO. / Charlie Nye / The Star 2007 file photo

BioCrossroads will be able to remain in the business of seeding life-science startups, thanks to $8.25 million in payments.

The new dose of money should provide hard-to-get seed capital for about 16 promising biotech and other life-science companies across the state over the next four years, according to BioCrossroads, which promotes the 50,000-employee life-science industry in Indiana.

BioCrossroads' first seed fund, established in 2005 with $6 million, ran out of money this year after investing in 12 companies.

To read the full, original article click on this link: $8.25M seed fund lets BioCrossroads help startups | Indianapolis Star | indystar.com